Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Alexander

Showing results (251-260 of 267) with videos related to

Pageof 27
Sort By:
Annals of Surgical Oncology|December 13, 2012
A novel nomogram for peritoneal mesothelioma predicts survivalNicholas P Schaub, Meghna Alimchandani, Martha Quezado, et al.
CA: a Cancer Journal for Clinicians|July 9, 2019
Mesothelioma: Scientific clues for prevention, diagnosis, and therapyMichele Carbone, Prasad S Adusumilli, H Richard Alexander, et al.
Journal of Medicinal Chemistry|September 23, 2021
JNJ-67569762, A 2-Aminotetrahydropyridine-Based Selective BACE1 Inhibitor Targeting the S3 Pocket: From Discovery to Clinical CandidateFrederik J R Rombouts, Ken-Ichi Kusakabe, Richard Alexander, et al.
Journal of Medicinal Chemistry|September 18, 2015
1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors: From Hit Generation to Orally Bioavailable Brain Penetrant LeadsFrederik J R Rombouts, Gary Tresadern, Oscar Delgado, et al.
Protein Science : a Publication of the Protein Society|February 11, 2011
Crystal structure of a soluble form of human monoglyceride lipase in complex with an inhibitor at 1.35 Å resolutionCéline Schalk-Hihi, Carsten Schubert, Richard Alexander, et al.
Tumori|April 13, 2012
Prospective Registry On Mesothelioma Peritonei Treatment (PROMPT): study design and rationaleChristopher Cao, Tristan D Yan, David L Morris, et al.
The Journal of Biological Chemistry|September 2, 2017
Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activationRobert H Scannevin, Richard Alexander, Tara Mezzasalma Haarlander, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2006
Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020Wendy R Cornett, Linda M McCall, Rebecca P Petersen, et al.
Cell Research|August 2, 2018
Suppression of m<sup>6</sup>A reader Ythdf2 promotes hematopoietic stem cell expansionZhenrui Li, Pengxu Qian, Wanqing Shao, et al.
Science (New York, N.Y.)|December 11, 2020
Genetic interaction mapping informs integrative structure determination of protein complexesHannes Braberg, Ignacia Echeverria, Stefan Bohn, et al.
Pageof 27

Showing results (251-260 of 267) with videos related to

Sort By:
Pageof 27
Annals of Surgical Oncology|December 13, 2012
A novel nomogram for peritoneal mesothelioma predicts survivalNicholas P Schaub, Meghna Alimchandani, Martha Quezado, et al.
CA: a Cancer Journal for Clinicians|July 9, 2019
Mesothelioma: Scientific clues for prevention, diagnosis, and therapyMichele Carbone, Prasad S Adusumilli, H Richard Alexander, et al.
Journal of Medicinal Chemistry|September 23, 2021
JNJ-67569762, A 2-Aminotetrahydropyridine-Based Selective BACE1 Inhibitor Targeting the S3 Pocket: From Discovery to Clinical CandidateFrederik J R Rombouts, Ken-Ichi Kusakabe, Richard Alexander, et al.
Journal of Medicinal Chemistry|September 18, 2015
1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors: From Hit Generation to Orally Bioavailable Brain Penetrant LeadsFrederik J R Rombouts, Gary Tresadern, Oscar Delgado, et al.
Protein Science : a Publication of the Protein Society|February 11, 2011
Crystal structure of a soluble form of human monoglyceride lipase in complex with an inhibitor at 1.35 Å resolutionCéline Schalk-Hihi, Carsten Schubert, Richard Alexander, et al.
Tumori|April 13, 2012
Prospective Registry On Mesothelioma Peritonei Treatment (PROMPT): study design and rationaleChristopher Cao, Tristan D Yan, David L Morris, et al.
The Journal of Biological Chemistry|September 2, 2017
Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activationRobert H Scannevin, Richard Alexander, Tara Mezzasalma Haarlander, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2006
Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020Wendy R Cornett, Linda M McCall, Rebecca P Petersen, et al.
Cell Research|August 2, 2018
Suppression of m<sup>6</sup>A reader Ythdf2 promotes hematopoietic stem cell expansionZhenrui Li, Pengxu Qian, Wanqing Shao, et al.
Science (New York, N.Y.)|December 11, 2020
Genetic interaction mapping informs integrative structure determination of protein complexesHannes Braberg, Ignacia Echeverria, Stefan Bohn, et al.
Pageof 27